Search Results

• • 2 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma.

  Authors:Yunzhen Qian, Yitao Gong, Yu Liu, Yusheng Chen, Ruijie Wang, Zhengjie Dai, et al.From:Journal of Immunology Research (Vol. 2022) Peer-Reviewed

  July 21, 20226,202 words Article 1400LBackground. Pancreatic ductal adenocarcinoma (PDAC) displays a typical mucin expression pattern which is characterized by MUC1 positive, MUC2 negative, and MUC5AC positive. More and more evidences show that mucins are...

• Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.

  Authors:Yunzhen Qian, Yitao Gong, Zhiyao Fan, Guopei Luo, Qiuyi Huang, Shengming Deng, et al.From:Journal of Hematology & Oncology (Vol. 13, Issue 1) Peer-Reviewed

  Oct. 2, 202010,215 words Article 1440LPancreatic ductal adenocarcinoma (PDAC) is a malignancy characterized by a poor prognosis and high mortality rate. Genetic mutations and altered molecular pathways serve as targets in precise therapy. Using...